Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$145.54 - $178.83 $8.22 Million - $10.1 Million
-56,457 Reduced 10.42%
485,303 $84.1 Million
Q1 2024

May 09, 2024

BUY
$165.67 - $199.94 $74.8 Million - $90.2 Million
451,242 Added 498.51%
541,760 $91.7 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $5.59 Million - $7.38 Million
36,908 Added 68.85%
90,518 $17.9 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $8.96 Million - $10.3 Million
53,610 New
53,610 $9.33 Million
Q4 2022

Feb 10, 2023

BUY
$131.14 - $157.47 $161,564 - $194,003
1,232 Added 62.0%
3,219 $471,000
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $37,962 - $46,732
-256 Reduced 11.41%
1,987 $295,000
Q2 2022

Aug 05, 2022

SELL
$155.97 - $200.09 $1.36 Million - $1.74 Million
-8,713 Reduced 79.53%
2,243 $386,000
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $1.82 Million - $2.35 Million
10,055 Added 1115.98%
10,956 $2.07 Million
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $26.5 Million - $33.8 Million
-136,999 Reduced 99.35%
901 $220,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $13.6 Million - $15.1 Million
-72,084 Reduced 34.33%
137,900 $26.8 Million
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $3.9 Million - $4.7 Million
-25,025 Reduced 10.65%
209,984 $39.1 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $13.5 Million - $15.9 Million
93,596 Added 66.19%
235,009 $37 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $10.5 Million - $11.6 Million
66,631 Added 89.1%
141,413 $23.4 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $10.3 Million - $12.4 Million
74,782 New
74,782 $12.4 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $2.63 Million - $3.34 Million
-23,468 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $2.17 Million - $3.4 Million
23,468 New
23,468 $2.76 Million
Q4 2019

Feb 12, 2020

SELL
$116.25 - $133.25 $912,562 - $1.05 Million
-7,850 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $883,674 - $1.01 Million
7,850 New
7,850 $978,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.